LMR Partners’s SpringWorks Therapeutics SWTX Stock Holding History

LMR Partners’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000,000	Closed	-$47M	–	1646
2025 Q2	$47M	Buy	1,000,000 +900,000	+900%	+$40M	0.34%	60
2025 Q1	$4.41M	Buy	+100,000	New	+$4.6M	0.04%	454

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

LMR Partners's SWTX Position: Q3 2025 in Review

LMR Partners sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 279,700 shares — an estimated $13.1M sold.

LMR Partners first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $13.1M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

LMR Partners reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
LMR Partners sold 279,700 SpringWorks Therapeutics shares in Q3 2025, an estimated $13.1M.
LMR Partners first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
LMR Partners's SpringWorks Therapeutics position peaked at $13.1M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on LMR Partners's 13F filing for Q3 2025, filed 14 Nov 2025.